P

Inventor

CAO CHUANHAI

US16 patents
⚠️ This page may combine multiple inventors who share the name “CAO CHUANHAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV SOUTH FLORIDA

6 patents
US12145969B2Nov 19, 2024

Compositions and methods relating to novel sulfono-gamma-AA peptides

UNIV SOUTH FLORIDA0 citations62
US11254704B2Feb 22, 2022

Compounds and methods for reducing or inhibiting aggregation of proteins in a subject

UNIV SOUTH FLORIDA0 citations62
US10836793B2Nov 17, 2020

Compounds for the treatment of neurodegenerative diseases

UNIV SOUTH FLORIDA1 citations62
US11446276B2Sep 20, 2022

Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer's disease

UNIV SOUTH FLORIDA1 citations61
US8383347B1Feb 26, 2013

Method of diagnosing or assessing risk for Parkinson's disease or Alzheimer's disease using TCR clonality

UNIV SOUTH FLORIDA1 citations49
US10022420B2Jul 17, 2018

Methods of synthesizing γ-AApeptides, γ-AApeptide building blocks, γ-AApeptide libraries, and γ-AApeptide inhibitors of Aβ40 aggregates

UNIV SOUTH FLORIDA0 citations48

CAO CHUANHAI

4 patents
US11065225B1Jul 20, 2021

Ultra-low dose THC as a potential therapeutic and prophylactic agent for Alzheimer's disease

CAO CHUANHAI7 citations81
US8188046B2May 29, 2012

Amyloid beta peptides and methods of use

CAO CHUANHAI2 citations60
US10653759B2May 19, 2020

Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of Parkinson's disease

CAO CHUANHAI0 citations46
US10155030B2Dec 18, 2018

Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of parkinsons disease

CAO CHUANHAI0 citations46

CAI JIANFENG

2 patents
US9645155B2May 9, 2017

Methods of synthesizing γ-aapeptides, γ-aapeptide building blocks, γ-aapeptide libraries, and γ-aapeptide inhibitors of Aβ40 aggregates

CAI JIANFENG4 citations68
US10538553B2Jan 21, 2020

Compounds for the treatment of neurodegenerative diseases

CAI JIANFENG0 citations50

ARENDASH GARY W

2 patents
US9238149B2Jan 19, 2016

Prevention and treatment of alzheimer'S disease through electromagnetic field exposure

ARENDASH GARY W2 citations57
US10149982B2Dec 11, 2018

Prevention and treatment of brain diseases and disorders related to abnormal protein aggregation through electromagnetic field treatment

ARENDASH GARY W0 citations36

MEGANANO BIOTECH INC

1 patent
US12329807B2Jun 17, 2025

Dead antigen stimulated immature heterogenous dendritic cells as therapeutics for diseases

MEGANANO BIOTECH INC0 citations54

UGEN KENNETH E

1 patent
US8067430B1Nov 29, 2011

Anti-HIV activity of the opioid antagonist naloxone

UGEN KENNETH E0 citations35